Institutional shares held 91.7 Million
6.17M calls
6.95M puts
Total value of holdings $778M
$52.3M calls
$59M puts
Market Cap $663M
78,215,104 Shares Out.
Institutional ownership 117.23%
# of Institutions 309


Latest Institutional Activity in NVAX

Top Purchases

Q2 2025
Ubs Group Ag Shares Held: 2.26M ($19.1M)
Q2 2025
Jupiter Asset Management LTD Shares Held: 880K ($7.47M)
Q2 2025
Allianz Asset Management Gmb H Shares Held: 537K ($4.55M)
Q2 2025
Wells Fargo & Company Shares Held: 667K ($5.65M)
Q2 2025
Susquehanna International Group, LLP Shares Held: 932K ($7.9M)

Top Sells

Q2 2025
Rock Springs Capital Management LP Shares Held: 53.9K ($457K)
Q2 2025
Two Sigma Advisers, LP Shares Held: 21.7K ($184K)
Q2 2025
Deep Track Capital, LP Shares Held: 999K ($8.47M)
Q2 2025
State Of Wisconsin Investment Board Shares Held: 66.5K ($564K)
Q2 2025
Vanguard Group Inc Shares Held: 15.4M ($131M)

About NVAX

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.


Insider Transactions at NVAX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
529K Shares
From 13 Insiders
Exercise of conversion of derivative security 524K shares
Grant, award, or other acquisition 5.25K shares
Sell / Disposition
212K Shares
From 7 Insiders
Payment of exercise price or tax liability 197K shares
Open market or private sale 14.2K shares

Track Institutional and Insider Activities on NVAX

Follow NOVAVAX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVAX shares.

Notify only if

Insider Trading

Get notified when an Novavax Inc insider buys or sells NVAX shares.

Notify only if

News

Receive news related to NOVAVAX INC

Track Activities on NVAX